Association between serum cholesterol and bone mineral density

Bone

Volumn 44, Issue 2, 2009, Pages 208-213

  Makovey, Joanna ^a   Chen, Jian Sheng ^a   Hayward, Chris ^b   Williams, Frances M K ^c   Sambrook, Philip N ^a  

^a ROYAL NORTH SHORE HOSPITAL   (Australia)

^b ST VINCENT S HOSPITAL   (Australia)

^c ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Body composition; Bone mineral density; Cholesterol; HDL; HRT; LDL; Menopause; Triglycerides

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN;

ADULT; AGED; ARTICLE; BONE DENSITY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; HORMONE SUBSTITUTION; HUMAN; HUMAN EXPERIMENT; LIPID BLOOD LEVEL; LUMBAR SPINE; MENOPAUSE; NORMAL HUMAN; PREMENOPAUSE;

ADULT; AGED; AGED, 80 AND OVER; BONE DENSITY; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; FEMALE; HUMANS; LUMBAR VERTEBRAE; MIDDLE AGED; REGRESSION ANALYSIS; TRIGLYCERIDES;

EID: 58249114884     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2008.09.020     Document Type: Article

References (45)

1. Orozco P. Atherogenic lipid profile and elevated lipoprotein (a) are associated with lower bone mineral density in early postmenopausal overweight women. Eur. J. Epidemiol. 19 (2004) 1105-1112
2. Tanko L.B., Bagger Y.Z., Nielsen S.B., and Christiansen C. Does serum cholesterol contribute to vertebral bone loss in postmenopausal women?. Bone 32 (2003) 8-14
3. Uyama O., Yoshimoto Y., Yamamoto Y., and Kawai A. Bone changes and carotid atherosclerosis in postmenopausal women. Stroke 28 (1997) 1730-1732
4. Samelson E.J., Cupples L.A., Hannan M.T., Wilson P.W., Williams S.A., Vaccarino V., et al. Long-term effects of serum cholesterol on bone mineral density in women and men: the Framingham Osteoporosis Study. Bone 34 (2004) 557-561
5. Solomon D.H., Avorn J., Canning C.F., and Wang P.S. Lipid levels and bone mineral density. Am. J. Med. 118 (2005) 1414
6. Wu L.Y., Yang T.C., Kuo S.W., Hsiao C.F., Hung Y.J., Hsieh C.H., et al. Correlation between bone mineral density and plasma lipids in Taiwan. Endocr. Res. 29 (2003) 317-325
7. Cui L.H., Shin M.H., Chung E.K., Lee Y.H., Kweon S.S., Park K.S., et al. Association between bone mineral densities and serum lipid profiles of pre- and post-menopausal rural women in South Korea. Osteoporos. Int. 16 (2005) 1975-1981
8. Dennison E.M., Syddall H.E., Aihie S.A., Martin H.J., and Cooper C. Lipid profile, obesity and bone mineral density: the Hertfordshire Cohort Study. QJM 100 (2007) 297-303
9. Brownbill R.A., and Ilich J.Z. Lipid profile and bone paradox: higher serum lipids are associated with higher bone mineral density in postmenopausal women. J. Womens Health (Larchmt) 15 (2006) 261-270
10. D'Amelio P., Pescarmona G.P., Gariboldi A., and Isaia G.C. High density lipoproteins (HDL) in women with postmenopausal osteoporosis: a preliminary study. Menopause 8 (2001) 429-432
11. D'Amelio P., Di B.S., Tamone C., Ravazzoli M.G., Cristofaro M.A., Di S.M., et al. HDL cholesterol and bone mineral density in normal-weight postmenopausal women: is there any possible association?. Panminerva Med. 50 (2008) 89-96
12. Poli A., Bruschi F., Cesana B., Rossi M., Paoletti R., and Crosignani P.G. Plasma low-density lipoprotein cholesterol and bone mass densitometry in postmenopausal women. Obstet. Gynecol. 102 (2003) 922-926
13. Yamaguchi T., Sugimoto T., Yano S., Yamauchi M., Sowa H., Chen Q., et al. Plasma lipids and osteoporosis in postmenopausal women. Endocr. J. 49 (2002) 211-217
14. Browner W.S., Seeley D.G., Vogt T.M., and Cummings S.R. Non-trauma mortality in elderly women with low bone mineral density. Study of Osteoporotic Fractures Research Group. Lancet 338 (1991) 355-358
15. Von der Recke P., Hansen M.A., and Hassager C. The association between low bone mass at the menopause and cardiovascular mortality. Am. J. Med. 106 (1999) 273-278
16. Barengolts E.I., Berman M., Kukreja S.C., Kouznetsova T., Lin C., and Chomka E.V. Osteoporosis and coronary atherosclerosis in asymptomatic postmenopausal women. Calcif. Tissue Int. 62 (1998) 209-213
17. Kiel D.P., Kauppila L.I., Cupples L.A., Hannan M.T., O'Donnell C.J., and Wilson P.W. Bone loss and the progression of abdominal aortic calcification over a 25 year period: the Framingham Heart Study. Calcif. Tissue Int. 68 (2001) 271-276
18. Browner W.S., Pressman A.R., Nevitt M.C., Cauley J.A., and Cummings S.R. Association between low bone density and stroke in elderly women. The study of osteoporotic fractures. Stroke 24 (1993) 940-946
19. Naganathan V., Macgregor A., Snieder H., Nguyen T., Spector T., and Sambrook P. Gender differences in the genetic factors responsible for variation in bone density and ultrasound. J. Bone Miner. Res. 17 (2002) 725-733
20. Makovey J., Naganathan V., and Sambrook P. Gender differences in relationships between body composition components, their distribution and bone mineral density: a cross-sectional opposite sex twin study. Osteoporos. Int. 16 (2005) 1495-1505
21. Makovey J., Nguyen T.V., Naganathan V., Wark J.D., and Sambrook P.N. Genetic effects on bone loss in peri- and postmenopausal women: a longitudinal twin study. J. Bone Miner. Res. 22 (2007) 1773-1780
22. Friedewald W.T., Levy R.I., and Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18 (1972) 499-502
23. Naganathan V., and Sambrook P. Gender differences in volumetric bone density: a study of opposite-sex twins. Osteoporos. Int. 14 (2003) 564-569
24. Hulley S., Grady D., Bush T., Furberg C., Herrington D., Riggs B., et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA 280 (1998) 605-613
25. Darling G.M., Johns J.A., McCloud P.I., and Davis S.R. Estrogen and progestin compared with simvastatin for hypercholesterolemia in postmenopausal women. N. Engl. J. Med. 337 (1997) 595-601
26. Herrington D.M., Reboussin D.M., Brosnihan K.B., Sharp P.C., Shumaker S.A., Snyder T.E., et al. Effects of estrogen replacement on the progression of coronary-artery atherosclerosis. N. Engl. J. Med. 343 (2000) 522-529
27. Thomsen A.B., Silvestri S., Haarbo J., Christiansen C., and Bjarnason N.H. Associated response in bone and lipids during hormone replacement therapy. Maturitas 47 (2004) 39-45
28. Parhami F., Morrow A.D., Balucan J., Leitinger N., Watson A.D., Tintut Y., et al. Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differentiation. A possible explanation for the paradox of arterial calcification in osteoporotic patients. Arterioscler. Thromb. Vasc. Biol. 17 (1997) 680-687
29. Parhami F., Garfinkel A., and Demer L.L. Role of lipids in osteoporosis. Arterioscler. Thromb. Vasc. Biol. 20 (2000) 2346-2348
30. Parhami F., Tintut Y., Beamer W.G., Gharavi N., Goodman W., and Demer L.L. Atherogenic high-fat diet reduces bone mineralization in mice. J. Bone Miner. Res. 16 (2001) 182-188
31. Mundy G., Garrett R., Harris S., Chan J., Chen D., Rossini G., et al. Stimulation of bone formation in vitro and in rodents by statins. Science 286 (1999) 1946-1949
32. Edwards C.J., Hart D.J., and Spector T.D. Oral statins and increased bone-mineral density in postmenopausal women. Lancet 355 (2000) 2218-2219
33. Meier C.R., Schlienger R.G., Kraenzlin M.E., Schlegel B., and Jick H. Statin drugs and the risk of fracture. JAMA 284 (2000) 1921-1922
34. Garrett I.R., Gutierrez G., and Mundy G.R. Statins and bone formation. Curr. Pharm. Des. 7 (2001) 715-736
35. Meier C.R., Schlienger R.G., Kraenzlin M.E., Schlegel B., and Jick H. Statins and fracture risk. JAMA 286 (2001) 669-670
36. Mundy G.R. Statins and their potential for osteoporosis. Bone 29 (2001) 495-497
37. Garrett I.R., and Mundy G.R. The role of statins as potential targets for bone formation. Arthritis Res. 4 (2002) 237-240
38. Reid I.R., Hague W., Emberson J., Baker J., Tonkin A., Hunt D., et al. Effect of pravastatin on frequency of fracture in the LIPID study: secondary analysis of a randomised controlled trial. Long-term intervention with pravastatin in ischaemic disease. Lancet 357 (2001) 509-512
39. van Staa T.P., Wegman S., de Vries F., Leufkens B., and Cooper C. Use of statins and risk of fractures. JAMA 285 (2001) 1850-1855
40. Dennison E.M., Syddall H.E., Aihie S.A., Martin H.J., and Cooper C. Lipid profile, obesity and bone mineral density: the Hertfordshire Cohort Study. QJM 100 (2007) 297-303
41. Brownbill R.A., and Ilich J.Z. Lipid profile and bone paradox: higher serum lipids are associated with higher bone mineral density in postmenopausal women. J. Womens Health (Larchmt) 15 (2006) 261-270
42. D'Amelio P., Pescarmona G.P., Gariboldi A., and Isaia G.C. High density lipoproteins (HDL) in women with postmenopausal osteoporosis: a preliminary study. Menopause 8 (2001) 429-432
43. D'Amelio P., Di B.S., Tamone C., Ravazzoli M.G., Cristofaro M.A., Di S.M., et al. HDL cholesterol and bone mineral density in normal-weight postmenopausal women: is there any possible association?. Panminerva Med. 50 (2008) 89-96
44. Adami S., Braga V., Zamboni M., Gatti D., Rossini M., Bakri J., et al. Relationship between lipids and bone mass in 2 cohorts of healthy women and men. Calcif. Tissue Int. 74 (2004) 136-142
45. D'Amelio P., Pescarmona G.P., Gariboldi A., and Isaia G.C. High density lipoproteins (HDL) in women with postmenopausal osteoporosis: a preliminary study. Menopause 8 (2001) 429-432